Beneficial effects of interferon-alpha in a case with Behçet's disease

Internal Medicine

Volumn 39, Issue 8, 2000, Pages 667-669

  Aoki, Tomohiro ^a,c   Tanaka, Takayuki ^a   Akifuji, Youichi ^a   Ueki, Juichi ^a   Nakamura, Isao ^b   Nemoto, Ryosuke ^b   Ito, Kyutarou ^a  

^a TOTTORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b Tottori Pref Ctrl Hospital ^*  (Japan)

^c Tottori Prefectural Hospital   (Japan)

Author keywords

Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; COLCHICINE; DEXAMETHASONE; SULINDAC;

ADULT; APHTHOUS STOMATITIS; ARTHRITIS; ARTICLE; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; EPIDIDYMITIS; ERYTHEMA NODOSUM; EYE DISEASE; FEVER; FOLLICULITIS; GENITAL ULCER; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LIVER DYSFUNCTION; MALE; RECURRENT DISEASE;

EID: 0033859107     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.667     Document Type: Article

References (11)

1. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 335: 1078-1080, 1990.
2. O'Duffy JD. Behçet's syndrome. N Engl J Med 322: 326-328, 1990.
3. Hamuryudan V, Moral F, Yurdakul S, et al. Systemic interferon alpha 2b treatment in Behçet's syndrome. J Rheumatol 21: 1098-1100, 1994.
4. Alpsoy E, Yilmaz E, Basaran E. Interferon therapy for Behçet's disease. J Am Acad Dermatol 31: 617-619, 1994.
5. Zouboulis CC, Treudler R, Orfanos CE. Adamantiades-Behçet disease. Therapeutic administration of systemic recombinant interferon-alpha-2a. Hautarzt 44: 440-445, 1993.
6. Kötter I, Durk H, Eckstein A, Zierhut M, Fierlbeck G, Saal JG. Erosive arthritis and posterior uveitis in Behçet's disease: treatment with interferon alpha and interferon gamma. Clin Exp Rheumatol 14: 313-315, 1996.
7. Feron EJ, Rothova A, Van Hagen PM, Baarsma GS, Suttorp-Schulten MSA. Interferon-alpha-2b for refractory ocular Behçet's disease. Lancet 343: 1428, 1994.
8. Durand JM, Kaplanski G, Telle H, Soubeyrand J, Paulo F. Beneficial effects of interferon alpha 2b in Behçet's disease. Arthritis Rheum 36: 1025-1026, 1993.
9. Segawa F, Shimizu Y, Saito E, Kinoshita M. Behçet's disease induced by interferon therapy for chronic myelogenous leukemia. J Rheumatol 22: 1183-1184, 1995.
10. Emmi L, Brugnolo F, Marchione T. Pathogenesis and therapy of Behçet's disease. Ann Ital Med Int 12: 20-25, 1997.
11. Hu W, Hasan A, Wilson A, et al. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol 28: 2444-2455, 1998.